ALKERMES PLC (ALKS) Fundamental Analysis & Valuation
NASDAQ:ALKS • IE00B56GVS15
Current stock price
27.76 USD
+0.12 (+0.43%)
At close:
27.76 USD
0 (0%)
After Hours:
This ALKS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ALKS Profitability Analysis
1.1 Basic Checks
- In the past year ALKS was profitable.
- ALKS had a positive operating cash flow in the past year.
- In multiple years ALKS reported negative net income over the last 5 years.
- ALKS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 9.72%, ALKS belongs to the best of the industry, outperforming 93.64% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 13.28%, ALKS belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 10.90%, ALKS belongs to the top of the industry, outperforming 94.41% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for ALKS is in line with the industry average of 19.44%.
- The 3 year average ROIC (18.21%) for ALKS is well above the current ROIC(10.90%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 13.28% | ||
| ROIC | 10.9% |
ROA(3y)14.74%
ROA(5y)6.76%
ROE(3y)22.64%
ROE(5y)9.68%
ROIC(3y)18.21%
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 16.37%, ALKS belongs to the top of the industry, outperforming 92.49% of the companies in the same industry.
- With an excellent Operating Margin value of 17.21%, ALKS belongs to the best of the industry, outperforming 93.45% of the companies in the same industry.
- ALKS has a Gross Margin of 86.69%. This is amongst the best in the industry. ALKS outperforms 88.63% of its industry peers.
- In the last couple of years the Gross Margin of ALKS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.21% | ||
| PM (TTM) | 16.37% | ||
| GM | 86.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.55%
GM growth 5Y0.92%
2. ALKS Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALKS is creating value.
- The number of shares outstanding for ALKS has been increased compared to 1 year ago.
- ALKS has more shares outstanding than it did 5 years ago.
- ALKS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- ALKS has an Altman-Z score of 5.32. This indicates that ALKS is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 5.32, ALKS is doing good in the industry, outperforming 73.22% of the companies in the same industry.
- There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 5.32 |
ROIC/WACC1.42
WACC7.7%
2.3 Liquidity
- A Current Ratio of 3.55 indicates that ALKS has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 3.55, ALKS is in line with its industry, outperforming 41.23% of the companies in the same industry.
- A Quick Ratio of 3.19 indicates that ALKS has no problem at all paying its short term obligations.
- ALKS's Quick ratio of 3.19 is on the low side compared to the rest of the industry. ALKS is outperformed by 61.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.55 | ||
| Quick Ratio | 3.19 |
3. ALKS Growth Analysis
3.1 Past
- The earnings per share for ALKS have decreased strongly by -40.76% in the last year.
- Measured over the past years, ALKS shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.92% on average per year.
- The Revenue has decreased by -5.25% in the past year.
- ALKS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.28% yearly.
EPS 1Y (TTM)-40.76%
EPS 3Y71.6%
EPS 5Y31.92%
EPS Q2Q%-72.38%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y9.9%
Revenue growth 5Y7.28%
Sales Q2Q%-10.57%
3.2 Future
- Based on estimates for the next years, ALKS will show a very strong growth in Earnings Per Share. The EPS will grow by 31.80% on average per year.
- Based on estimates for the next years, ALKS will show a quite strong growth in Revenue. The Revenue will grow by 11.16% on average per year.
EPS Next Y-135.86%
EPS Next 2Y-28.08%
EPS Next 3Y-2.65%
EPS Next 5Y31.8%
Revenue Next Year21.99%
Revenue Next 2Y12.92%
Revenue Next 3Y10.71%
Revenue Next 5Y11.16%
3.3 Evolution
- The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ALKS Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.14 indicates a correct valuation of ALKS.
- Based on the Price/Earnings ratio, ALKS is valued cheaper than 94.61% of the companies in the same industry.
- When comparing the Price/Earnings ratio of ALKS to the average of the S&P500 Index (25.70), we can say ALKS is valued slightly cheaper.
- The Forward Price/Earnings Ratio is negative for ALKS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.14 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- ALKS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALKS is cheaper than 94.99% of the companies in the same industry.
- ALKS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALKS is cheaper than 97.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.63 | ||
| EV/EBITDA | 13.58 |
4.3 Compensation for Growth
- The decent profitability rating of ALKS may justify a higher PE ratio.
- A cheap valuation may be justified as ALKS's earnings are expected to decrease with -2.65% in the coming years.
PEG (NY)N/A
PEG (5Y)0.51
EPS Next 2Y-28.08%
EPS Next 3Y-2.65%
5. ALKS Dividend Analysis
5.1 Amount
- No dividends for ALKS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ALKS Fundamentals: All Metrics, Ratios and Statistics
27.76
+0.12 (+0.43%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25 2026-02-25/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners109.8%
Inst Owner Change2.03%
Ins Owners1.6%
Ins Owner Change5.8%
Market Cap4.63B
Revenue(TTM)1.48B
Net Income(TTM)241.66M
Analysts81.67
Price Target44.69 (60.99%)
Short Float %10.94%
Short Ratio9.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)21.45%
Min EPS beat(2)-16.95%
Max EPS beat(2)59.84%
EPS beat(4)3
Avg EPS beat(4)31.82%
Min EPS beat(4)-16.95%
Max EPS beat(4)72.36%
EPS beat(8)4
Avg EPS beat(8)15.4%
EPS beat(12)7
Avg EPS beat(12)24.7%
EPS beat(16)10
Avg EPS beat(16)139.34%
Revenue beat(2)1
Avg Revenue beat(2)3.48%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)8.51%
Revenue beat(4)2
Avg Revenue beat(4)4.47%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)12.13%
Revenue beat(8)3
Avg Revenue beat(8)2.64%
Revenue beat(12)6
Avg Revenue beat(12)3.42%
Revenue beat(16)9
Avg Revenue beat(16)2.75%
PT rev (1m)0%
PT rev (3m)-0.14%
EPS NQ rev (1m)-491.83%
EPS NQ rev (3m)-616.77%
EPS NY rev (1m)-141.15%
EPS NY rev (3m)-140.46%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)-0.87%
Revenue NY rev (3m)-1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.14 | ||
| Fwd PE | N/A | ||
| P/S | 3.13 | ||
| P/FCF | 9.63 | ||
| P/OCF | 8.88 | ||
| P/B | 2.54 | ||
| P/tB | 2.67 | ||
| EV/EBITDA | 13.58 |
EPS(TTM)1.72
EY6.2%
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)2.88
FCFY10.38%
OCF(TTM)3.12
OCFY11.26%
SpS8.86
BVpS10.92
TBVpS10.41
PEG (NY)N/A
PEG (5Y)0.51
Graham Number20.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.72% | ||
| ROE | 13.28% | ||
| ROCE | 13.07% | ||
| ROIC | 10.9% | ||
| ROICexc | 15.63% | ||
| ROICexgc | 16.66% | ||
| OM | 17.21% | ||
| PM (TTM) | 16.37% | ||
| GM | 86.69% | ||
| FCFM | 32.55% |
ROA(3y)14.74%
ROA(5y)6.76%
ROE(3y)22.64%
ROE(5y)9.68%
ROIC(3y)18.21%
ROIC(5y)N/A
ROICexc(3y)43.15%
ROICexc(5y)N/A
ROICexgc(3y)50.12%
ROICexgc(5y)N/A
ROCE(3y)21.84%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.55%
GM growth 5Y0.92%
F-Score6
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 148.79% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 185.24% | ||
| Profit Quality | 198.76% | ||
| Current Ratio | 3.55 | ||
| Quick Ratio | 3.19 | ||
| Altman-Z | 5.32 |
F-Score6
WACC7.7%
ROIC/WACC1.42
Cap/Depr(3y)110.09%
Cap/Depr(5y)83%
Cap/Sales(3y)2.59%
Cap/Sales(5y)2.72%
Profit Quality(3y)136.19%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.76%
EPS 3Y71.6%
EPS 5Y31.92%
EPS Q2Q%-72.38%
EPS Next Y-135.86%
EPS Next 2Y-28.08%
EPS Next 3Y-2.65%
EPS Next 5Y31.8%
Revenue 1Y (TTM)-5.25%
Revenue growth 3Y9.9%
Revenue growth 5Y7.28%
Sales Q2Q%-10.57%
Revenue Next Year21.99%
Revenue Next 2Y12.92%
Revenue Next 3Y10.71%
Revenue Next 5Y11.16%
EBIT growth 1Y-39.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.82%
EBIT Next 3Y26.72%
EBIT Next 5Y26.75%
FCF growth 1Y18.41%
FCF growth 3YN/A
FCF growth 5Y63.91%
OCF growth 1Y18.59%
OCF growth 3Y191.61%
OCF growth 5Y44.45%
ALKERMES PLC / ALKS Fundamental Analysis FAQ
What is the fundamental rating for ALKS stock?
ChartMill assigns a fundamental rating of 6 / 10 to ALKS.
What is the valuation status of ALKERMES PLC (ALKS) stock?
ChartMill assigns a valuation rating of 5 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.
Can you provide the profitability details for ALKERMES PLC?
ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for ALKS stock?
The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -135.86% in the next year.